{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:10:51Z","timestamp":1790892651037,"version":"4.1.0"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"19","license":[{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Purpose<\/jats:title>\n                  <jats:p>Neuromuscular blocking agents (NMBAs) are commonly used during surgery, and restoring neuromuscular function at the end of surgery is vital in preventing complications of residual paralysis. Recent guidelines from the American Society of Anesthesiology recommend using sugammadex over neostigmine; however, sugammadex is significantly more expensive than neostigmine and may increase drug expenditure for pharmacy departments. This review summarizes evidence evaluating sugammadex dose adjustments and the potential of these dose adjustments to lead to cost savings for pharmacy departments.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Summary<\/jats:title>\n                  <jats:p>We found evidence suggesting that the manufacturer-recommended sugammadex dose may not be needed in many patients and that dosing based on an adjusted body weight or based on depth of neuromuscular blockade may lead to lower sugammadex usage. Combining sugammadex with neostigmine could also decrease the dose of sugammadex required. We have highlighted the importance of objective neuromuscular monitoring to guide sugammadex dosing and evaluation for residual neuromuscular blockade. Cost savings for pharmacy departments may be realized by these alternative dosing strategies and\/or vial-splitting practices.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Implementing practices related to sugammadex vial splitting and dose adjustment based on body weight and depth of neuromuscular blockade shows potential benefits in terms of sugammadex cost savings.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajhp\/zxae124","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T06:39:10Z","timestamp":1715323150000},"page":"e575-e583","source":"Crossref","is-referenced-by-count":9,"title":["The impact of sugammadex dosing and administration practices on potential cost savings for pharmacy departments"],"prefix":"10.1093","volume":"81","author":[{"given":"Dustin D","family":"Linn","sequence":"first","affiliation":[{"name":"Philips North America , Cambridge, MA"},{"name":"Department of Pharmacy, Parkview Health , Fort Wayne, IN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnathan R","family":"Renew","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, Mayo Clinic , Jacksonville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,10]]},"reference":[{"issue":"4","key":"2024092319514811400_CIT0001","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/ALN.0b013e3181cded07","article-title":"Residual paralysis after emergence from anesthesia","volume":"112","author":"Plaud","year":"2010","journal-title":"Anesthesiology"},{"key":"2024092319514811400_CIT0002","doi-asserted-by":"crossref","first-page":"e6329","DOI":"10.1136\/bmj.e6329","article-title":"Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study","volume":"345","author":"Grosse-Sundrup","year":"2012","journal-title":"BMJ"},{"issue":"6","key":"2024092319514811400_CIT0003","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/ALN.0000000000000674","article-title":"Dose-dependent association between intermediate-acting neuromuscular-blocking agents and postoperative respiratory complications","volume":"122","author":"McLean","year":"2015","journal-title":"Anesthesiology"},{"issue":"4","key":"2024092319514811400_CIT0004","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/ALN.0000000000001279","article-title":"Nondepolarizing neuromuscular blocking agents, reversal, and risk of postoperative pneumonia","volume":"125","author":"Bulka","year":"2016","journal-title":"Anesthesiology"},{"issue":"5","key":"2024092319514811400_CIT0005","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00540-020-02836-1","article-title":"History of the development of antagonists for neuromuscular blocking agents","volume":"34","author":"Suzuki","year":"2020","journal-title":"J Anesth"},{"issue":"5","key":"2024092319514811400_CIT0006","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1213\/ANE.0000000000002562","article-title":"Incidence of anaphylaxis associated with sugammadex","volume":"126","author":"Miyazaki","year":"2018","journal-title":"Anesth Analg"},{"issue":"2","key":"2024092319514811400_CIT0007","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/joacp.JOACP_383_19","article-title":"Sugammadex and anaphylaxis: an analysis of 33 published cases","volume":"37","author":"Arslan","year":"2021","journal-title":"J Anaesthesiol Clin Pharmacol"},{"issue":"1","key":"2024092319514811400_CIT0008","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/ALN.0000000000004379","article-title":"2023 American Society of Anesthesiologists practice guidelines for monitoring and antagonism of neuromuscular blockade: a report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade","volume":"138","author":"Thilen","year":"2023","journal-title":"Anesthesiology"},{"issue":"2","key":"2024092319514811400_CIT0009","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1213\/ANE.0000000000004833","article-title":"Fourth consensus guidelines for the management of postoperative nausea and vomiting","volume":"131","author":"Gan","year":"2020","journal-title":"Anesth Analg"},{"issue":"1","key":"2024092319514811400_CIT0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1213\/ANE.0000000000004505","article-title":"Neostigmine versus sugammadex for reversal of neuromuscular blockade and effects on reintubation for respiratory failure or newly initiated noninvasive ventilation: an interrupted time series design","volume":"131","author":"Krause","year":"2020","journal-title":"Anesth Analg"},{"issue":"5","key":"2024092319514811400_CIT0011","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1213\/ANE.0000000000005080","article-title":"Utilization patterns of perioperative neuromuscular blockade reversal in the United States: a retrospective observational study from the Multicenter Perioperative Outcomes Group","volume":"131","author":"Dubovoy","year":"2020","journal-title":"Anesthesia & Analgesia"},{"issue":"2","key":"2024092319514811400_CIT0012","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1213\/ANE.0b013e3182999672","article-title":"Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block","volume":"117","author":"Kotake","year":"2013","journal-title":"Anesth Analg"},{"issue":"4","key":"2024092319514811400_CIT0013","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.bja.2020.05.063","article-title":"Forty years of neuromuscular monitoring and postoperative residual curarisation: a meta-analysis and evaluation of confidence in network meta-analysis","volume":"125","author":"Carvalho","year":"2020","journal-title":"Br J Anaesth"},{"issue":"2","key":"2024092319514811400_CIT0014","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/EJA.0000000000001769","article-title":"Peri-operative management of neuromuscular blockade: a guideline from the European Society of Anaesthesiology and Intensive Care","volume":"40","author":"Fuchs-Buder","year":"2023","journal-title":"Eur J Anaesthesiol"},{"issue":"5","key":"2024092319514811400_CIT0015","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1213\/01.ane.0000204288.24395.38","article-title":"Tactile fade detection with hand or wrist stimulation using train-of-four, double-burst stimulation, 50-hertz tetanus, 100-hertz tetanus, and acceleromyography","volume":"102","author":"Capron","year":"2006","journal-title":"Anesth Analg"},{"issue":"4","key":"2024092319514811400_CIT0016","doi-asserted-by":"crossref","first-page":"297","DOI":"10.5603\/AIT.2015.0042","article-title":"The use of sugammadex for the reversal of vecuronium-induced neuromuscular block following intracranial surgery","volume":"47","author":"Karwacki","year":"2015","journal-title":"Anaesthesiol Intensive Ther"},{"issue":"8","key":"2024092319514811400_CIT0017","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/j.1365-2044.1976.tb11947.x","article-title":"Management of anaesthesia during tracheal resection","volume":"31","author":"Ellis","year":"1976","journal-title":"Anaesthesia"},{"key":"2024092319514811400_CIT0018","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40560-020-00455-2","article-title":"Neuromuscular blockade management in the critically Ill patient","volume":"8","author":"Renew","year":"2020","journal-title":"J Intensive Care"},{"issue":"5","key":"2024092319514811400_CIT0019","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s12630-023-02439-w","article-title":"Comparison of visual and electromyographic assessments with train-of-four stimulation of the ulnar nerve: a prospective cohort study","volume":"70","author":"Renew","year":"2023","journal-title":"Can J Anaesth"},{"issue":"4","key":"2024092319514811400_CIT0020","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/00000542-200004000-00014","article-title":"The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium","volume":"92","author":"Sundman","year":"2000","journal-title":"Anesthesiology"},{"issue":"5","key":"2024092319514811400_CIT0021","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1213\/00000539-197509000-00021","article-title":"Train-of-4 quantitation of competitive neuromuscular block","volume":"54","author":"Lee","year":"1975","journal-title":"Anesth Analg"},{"issue":"2","key":"2024092319514811400_CIT0022","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1213\/00000539-199308000-00024","article-title":"Visual and tactile assessment of neuromuscular fade","volume":"77","author":"Brull","year":"1993","journal-title":"Anesth Analg"},{"issue":"1","key":"2024092319514811400_CIT0023","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1213\/ANE.0000000000002670","article-title":"Consensus statement on perioperative use of neuromuscular monitoring","volume":"127","author":"Naguib","year":"2018","journal-title":"Anesth Analg"},{"issue":"6","key":"2024092319514811400_CIT0024","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/ALN.0000000000004174","article-title":"Quantitative neuromuscular monitoring in clinical practice: a professional practice change initiative","volume":"136","author":"Weigel","year":"2022","journal-title":"Anesthesiology"},{"issue":"2","key":"2024092319514811400_CIT0025","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1213\/ANE.0000000000000261","article-title":"The implementation of quantitative electromyographic neuromuscular monitoring in an academic anesthesia department","volume":"119","author":"Todd","year":"2014","journal-title":"Anesth Analg"},{"issue":"5","key":"2024092319514811400_CIT0026","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/bja\/aeq226","article-title":"Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship","volume":"105","author":"P\u00fchringer","year":"2010","journal-title":"Br J Anaesth"},{"issue":"1","key":"2024092319514811400_CIT0027","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1213\/ANE.0b013e3181c3be3c","article-title":"A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia","volume":"110","author":"Duvaldestin","year":"2010","journal-title":"Anesth Analg"},{"issue":"2","key":"2024092319514811400_CIT0028","doi-asserted-by":"crossref","first-page":"138","DOI":"10.23736\/S0375-9393.16.11349-5","article-title":"Comparison of three different doses sugammadex based on ideal body weight for reversal of moderate rocuronium-induced neuromuscular blockade in laparoscopic bariatric surgery","volume":"83","author":"Abd El-Rahman","year":"2017","journal-title":"Minerva Anestesiol"},{"issue":"3","key":"2024092319514811400_CIT0029","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/ALN.0000000000001744","article-title":"Reversal of vecuronium-induced neuromuscular blockade with low-dose sugammadex at train-of-four count of four: a randomized controlled trial","volume":"127","author":"Asztalos","year":"2017","journal-title":"Anesthesiology"},{"issue":"1","key":"2024092319514811400_CIT0030","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/cts.13143","article-title":"Required dose of sugammadex or neostigmine for reversal of vecuronium-induced shallow residual neuromuscular block at a train-of-four ratio of 0.3","volume":"15","author":"He","year":"2022","journal-title":"Clin Transl Sci"},{"issue":"25","key":"2024092319514811400_CIT0031","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1056\/NEJMsa1909301","article-title":"Projected U.S. state-level prevalence of adult obesity and severe obesity","volume":"381","author":"Ward","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"2024092319514811400_CIT0032","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/00000542-200510000-00007","article-title":"First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide","volume":"103","author":"Gijsenbergh","year":"2005","journal-title":"Anesthesiology"},{"issue":"3","key":"2024092319514811400_CIT0033","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/anae.13344","article-title":"Appropriate dosing of sugammadex to reverse deep rocuronium-induced neuromuscular blockade in morbidly obese patients","volume":"71","author":"Loupec","year":"2016","journal-title":"Anaesthesia"},{"issue":"1","key":"2024092319514811400_CIT0034","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13054-021-03495-8","article-title":"Drug dosing in the critically ill obese patient: a focus on medications for hemodynamic support and prophylaxis","volume":"25","author":"Erstad","year":"2021","journal-title":"Crit Care"},{"issue":"1","key":"2024092319514811400_CIT0035","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/ALN.0b013e3182580409","article-title":"Sugammadex ideal body weight dose adjusted by level of neuromuscular blockade in laparoscopic bariatric surgery","volume":"117","author":"Llaurad\u00f3","year":"2012","journal-title":"Anesthesiology"},{"issue":"8","key":"2024092319514811400_CIT0036","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2044.2011.06782.x","article-title":"Ideal versus corrected body weight for dosage of sugammadex in morbidly obese patients","volume":"66","author":"Van Lancker","year":"2011","journal-title":"Anaesthesia"},{"issue":"1","key":"2024092319514811400_CIT0037","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.accpm.2015.09.003","article-title":"Reversal of neuromuscular blockade by sugammadex in laparoscopic bariatric surgery: in support of dose reduction","volume":"35","author":"Badaoui","year":"2016","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"3","key":"2024092319514811400_CIT0038","first-page":"219","article-title":"Sugammadex by ideal body weight versus 20% and 40% corrected weight in bariatric surgery \u2013 double-blind randomized clinical trial. Abstract in English; article in Portuguese","volume":"68","author":"Duarte NM da","year":"2018","journal-title":"Braz J Anesthesiol"},{"issue":"1","key":"2024092319514811400_CIT0039","doi-asserted-by":"crossref","first-page":"300060520985679","DOI":"10.1177\/0300060520985679","article-title":"Efficacy and safety of sugammadex doses calculated on the basis of corrected body weight and total body weight for the reversal of deep neuromuscular blockade in morbidly obese patients","volume":"49","author":"Li","year":"2021","journal-title":"J Int Med Res"},{"issue":"1","key":"2024092319514811400_CIT0040","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12871-021-01278-w","article-title":"Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: a randomized clinical trial","volume":"21","author":"Horrow","year":"2021","journal-title":"BMC Anesthesiol"},{"issue":"8","key":"2024092319514811400_CIT0041","doi-asserted-by":"crossref","first-page":"030006052211167","DOI":"10.1177\/03000605221116760","article-title":"Appropriate dosing of sugammadex for reversal of rocuronium-\/vecuronium-induced muscle relaxation in morbidly obese patients: a meta-analysis of randomized controlled trials","volume":"50","author":"Liao","year":"2022","journal-title":"J Int Med Res"},{"issue":"5","key":"2024092319514811400_CIT0042","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/ALN.0b013e3181f4182a","article-title":"Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block","volume":"113","author":"Schaller","year":"2010","journal-title":"Anesthesiology"},{"issue":"2","key":"2024092319514811400_CIT0043","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00540-020-02739-1","article-title":"Use of intraoperative neuromuscular monitor reduces the reversal dose of sugammadex: a single-center retrospective study","volume":"34","author":"Iwasaki","year":"2020","journal-title":"J Anesth"},{"issue":"1","key":"2024092319514811400_CIT0044","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/ALN.0000000000004578","article-title":"A dose-finding study of sugammadex for reversal of rocuronium in cardiac surgery patients and postoperative monitoring for recurrent paralysis","volume":"139","author":"Bowdle","year":"2023","journal-title":"Anesthesiology"},{"issue":"1","key":"2024092319514811400_CIT0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12871-017-0348-9","article-title":"Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy","volume":"17","author":"Aouad","year":"2017","journal-title":"BMC Anesthesiol"},{"issue":"24","key":"2024092319514811400_CIT0046","article-title":"Half-dose sugammadex with neostigmine versus full-dose sugammadex for reversal of rocuronium in laparoscopic bariatric surgery","volume":"12","author":"Ghanem","year":"2020","journal-title":"Ain-Shams Journal of Anesthesiology"},{"issue":"6","key":"2024092319514811400_CIT0047","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4097\/kjae.2015.68.6.547","article-title":"The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade","volume":"68","author":"Cheong","year":"2015","journal-title":"Korean J Anesthesiol"},{"issue":"3","key":"2024092319514811400_CIT0048","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jopan.2021.09.009","article-title":"Half-dose sugammadex after neostigmine versus neostigmine as a routine reversal agent: a pilot randomized trial","volume":"37","author":"Baysal","year":"2022","journal-title":"J Perianesth Nurs"},{"issue":"1","key":"2024092319514811400_CIT0049","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12871-018-0605-6","article-title":"Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction","volume":"18","author":"de Boer","year":"2018","journal-title":"BMC Anesthesiol"},{"key":"2024092319514811400_CIT0050","doi-asserted-by":"crossref","first-page":"110627","DOI":"10.1016\/j.jclinane.2021.110627","article-title":"Use of provider education, intra-operative decision support, and an email-feedback system in improving compliance with sugammadex dosage guideline and reducing drug expenditures","volume":"77","author":"Pregnall","year":"2022","journal-title":"J Clin Anesth"},{"issue":"5","key":"2024092319514811400_CIT0051","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/ALN.0000000000002946","article-title":"Effect of a Cognitive Aid on Reducing Sugammadex Use and Associated Costs: A Time Series Analysis","volume":"131","author":"Drzymalski","year":"2019","journal-title":"Anesthesiology"},{"issue":"7","key":"2024092319514811400_CIT0052","doi-asserted-by":"crossref","first-page":"e01223","DOI":"10.1213\/XAA.0000000000001223","article-title":"Reducing medication waste while improving access to sugammadex: a quality improvement project in medication stewardship","volume":"14","author":"Pimentel","year":"2020","journal-title":"A A Pract"},{"issue":"3","key":"2024092319514811400_CIT0053","first-page":"129","article-title":"Key vulnerabilities in the surgical environment: container mix-ups and syringe swaps","volume":"43","author":"Grissinger","year":"2018","journal-title":"P T"},{"issue":"5","key":"2024092319514811400_CIT0054","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1213\/ANE.0000000000005213","article-title":"Ease of application of various neuromuscular devices for routine monitoring","volume":"132","author":"Renew","year":"2021","journal-title":"Anesth Analg"},{"key":"2024092319514811400_CIT0055","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2147\/CEOR.S109951","article-title":"The use of sugammadex for bariatric surgery: analysis of recovery time from neuromuscular blockade and possible economic impact","volume":"8","author":"De Robertis","year":"2016","journal-title":"Clinicoecon Outcomes Res"},{"key":"2024092319514811400_CIT0056","doi-asserted-by":"crossref","first-page":"100184","DOI":"10.1016\/j.pcorm.2021.100184","article-title":"Universal quantitative neuromuscular blockade monitoring at an academic medical center \u2014 a multimodal analysis of the potential impact on clinical outcomes and total cost of care","volume":"24","author":"Edwards","year":"2021","journal-title":"Perioper Care Oper Room Manag"},{"issue":"2","key":"2024092319514811400_CIT0057","doi-asserted-by":"crossref","first-page":"e646","DOI":"10.1097\/pq9.0000000000000646","article-title":"Vial-splitting and repackaging into aliquot-specific syringes: a cost-effective and waste-decreasing strategy for sugammadex","volume":"8","author":"Amaya","year":"2023","journal-title":"Pediatr Qual Saf"},{"key":"2024092319514811400_CIT0058","author":"United States Pharmacopeial Convention","year":"2022"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxae124\/57839297\/zxae124.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/81\/19\/e575\/59260938\/zxae124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/81\/19\/e575\/59260938\/zxae124.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T19:52:11Z","timestamp":1727121131000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/81\/19\/e575\/7667983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,10]]},"references-count":58,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2024,5,10]]},"published-print":{"date-parts":[[2024,9,23]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxae124","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10,1]]},"published":{"date-parts":[[2024,5,10]]}}}